Search results - Portal of Medical Data Models (MDM-Portal)

Filter search results

Keywords

Coronary Artery Disease ×

Show more Keywords

Table of contents

Select data models

Selected data models

You must log in to select data models for download or further analysis.

289 Search results.

ICHOM Coronary Artery Disease - Peri-Inverventional Clinical Form

- 4/30/20 - 1 form, 8 itemgroups, 46 items, 1 language

Itemgroups: Administrative Data,Demographic factors,Baseline health status,Prior Treatments,TREATMENT VARIABLES,Acute complications of treatment,Major surgery complications,Major interventional cardiology complications

CORONARY ARTERY DISEASE DATA COLLECTION Version 2.0.3 Revised: April 5th, 2017 International Consortium for Health Outcomes Measurement (ICHOM), Source: http://www.ichom.org/ Notice: This work was conducted using resources from ICHOM, the International Consortium for Health Outcomes Measurement (www.ICHOM.org). The content is solely the responsibility of the authors and does not necessarily represent the official views of ICHOM. Conditions: Asymptomatic Coronary Artery Disease | Stable Angina | Acute Coronary Syndrome (Includes AMI) Treatment Approaches: Lifestyle Modification | Drug Therapy | Percutaneous Coronary Intervention (PCI) | Coronary Artery Bypass Grafting (CABG) This form contains peri-interventional clinical items. The items cover a timespan from prior to the intervention (e.g. PCI or CABG) until 30 days after it. They should be assessed at the entry event and at any new index event (e.g. new revascularization procedure or new diagnosis of ACS). Questionnaires used in this standard set: Rose Dyspnea Scale: The Rose Dyspnea Scale is free for all health care organizations, and a license is not needed. More information may be found at http://www.ahjonline.com/article/S0002-8703(09)00266-X/abstract Patient Health Questionnaire (PHQ-2): The PHQ-2 is free for all health care organizations, and a license is not needed. Copyright Pfizer, more Information on http://www.phqscreeners.com/ Seattle Angina Questionnaire (SAQ-7): Due to the need for a license for use of the SAQ-7 the actual questions of SAQ-7 will not be part of this version of the standard set. Publication: McNamara RL, Spatz ES, Kelley TA, et al. Standardized Outcome Measurement for Patients With Coronary Artery Disease: Consensus From the International Consortium for Health Outcomes Measurement (ICHOM). J Am Heart Assoc. 2015;4(5):e001767. Published 2015 May 19. doi:10.1161/JAHA.115.001767 For this version of the standard set, semantic annotation with UMLS CUIs has been added.

Eligibility Coronary Artery Disease NCT00669851

- 9/27/21 - 1 form, 2 itemgroups, 5 items, 1 language

Itemgroups: Inclusion Criteria,Exclusion Criteria

Acquiring Consensus for Contrast Echocardiography System Settings - ACCESS Study; ODM derived from: https://clinicaltrials.gov/show/NCT00669851

Eligibility Coronary Artery Disease NCT00864591

- 9/27/21 - 1 form, 2 itemgroups, 10 items, 1 language

Itemgroups: Inclusion Criteria,Exclusion Criteria

Stress Adenosine Cardiac Magnetic Resonance (MR) Comparison With Single Photon Emission Computed Tomography (SPECT) Imaging; ODM derived from: https://clinicaltrials.gov/show/NCT00864591

Eligibility Coronary Artery Disease NCT00765908

- 9/27/21 - 1 form, 2 itemgroups, 11 items, 1 language

Itemgroups: Inclusion Criteria,Exclusion Criteria

Ischaemic Pre-Conditioning in Elective Percutaneous Coronary Intervention (PCI) Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00765908

Eligibility Coronary Artery Disease NCT00735280

- 9/27/21 - 1 form, 2 itemgroups, 29 items, 1 language

Itemgroups: Inclusion Criteria,Exclusion Criteria

Reduced Dose of Unfractionated Heparin in Patients Undergoing PCI; ODM derived from: https://clinicaltrials.gov/show/NCT00735280

Eligibility Coronary Artery Disease NCT00741416

- 9/27/21 - 1 form, 2 itemgroups, 21 items, 1 language

Itemgroups: Inclusion Criteria,Exclusion Criteria

Biorepository: Indiana Health Study; ODM derived from: https://clinicaltrials.gov/show/NCT00741416

Eligibility Coronary Artery Disease NCT01086020

- 9/27/21 - 1 form, 2 itemgroups, 10 items, 1 language

Itemgroups: Inclusion Criteria,Exclusion Criteria

Atorvastatin Plus Ezetimibe on Coronary Plaque Progression; ODM derived from: https://clinicaltrials.gov/show/NCT01086020

Eligibility Coronary Artery Disease NCT00413244

- 9/20/21 - 1 form, 2 itemgroups, 16 items, 1 language

Itemgroups: Inclusion Criteria,Exclusion Criteria

The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Levels With Coronary Artery Disease After Successful Intervention of the Blockage or Narrowed Heart Artery; ODM derived from: https://clinicaltrials.gov/show/NCT00413244

Eligibility Coronary Artery Disease NCT00348101

- 9/20/21 - 1 form, 2 itemgroups, 10 items, 1 language

Itemgroups: Inclusion Criteria,Exclusion Criteria

Effects of Beta-Blocker Therapy and Phosphodiesterase Inhibition on Cardiac Neurohormonal Activation; ODM derived from: https://clinicaltrials.gov/show/NCT00348101

Eligibility Coronary Artery Disease NCT00321139

- 9/20/21 - 1 form, 2 itemgroups, 12 items, 1 language

Itemgroups: Inclusion Criteria,Exclusion Criteria

Assessment of Translesional Markers and Metabolomics; ODM derived from: https://clinicaltrials.gov/show/NCT00321139

Eligibility Coronary Artery Disease NCT00156845

- 9/17/21 - 1 form, 2 itemgroups, 8 items, 1 language

Itemgroups: Inclusion Criteria,Exclusion Criteria

Phase 3 Safety and Imaging Study of AI-700 in Patients With Suspected Coronary Artery Disease Undergoing Coronary Angiography; ODM derived from: https://clinicaltrials.gov/show/NCT00156845

Eligibility NCT00501059 Moderate Risk of CVD - Eligibility

- 9/17/21 - 1 form, 2 itemgroups, 31 items, 2 languages

Itemgroups: Inclusion Criteria,Exclusion Criteria

ODM derived from http://clinicaltrials.gov/show/NCT00501059

Please use this form for feedback, questions and suggestions for improvements.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.